ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE VS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (IKEMA): INTERIM ANALYSIS OF A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY
暂无分享,去创建一个
M. Dimopoulos | R. Hájek | P. Moreau | T. Facon | Â. Maiolino | J. Mikhael | I. Špička | S. Macé | M. Capra | G. Asset | T. Martin | K. Yong | M. Risse